Daneshmandi, Leila
Holt, Brian D.
Arnold, Anne M.
Laurencin, Cato T.
Sydlik, Stefanie A.
Funding for this research was provided by:
National Institutes of Health (DP-1-AR-068147)
Carnegie Mellon University (Startup)
Article History
Received: 9 November 2021
Accepted: 2 March 2022
First Online: 28 April 2022
Competing interests
: Dimension Inx LLC offers commercially available 3D printing services where, for example, an academic researcher develops a proprietary raw material and wants to form it into complex shapes and Dimension Inx receives that material and uses its proprietary processes and expertise to transform it into a 3D-printed object. For this work, the 3D printing of CaPG was a purchased service of Dimension Inx. The authors supplied GO to be 3D printed as a control matrix; however, Dimension Inx was unable to successfully print the supplied material. Thus, Dimension Inx provided 3D printed graphene scaffolds printed from their own graphene raw material. Outside of this work, the corresponding authors (C. Laurencin and S. Sydlik) are collaborating with Dimension Inx on additional projects. Dimension Inx Co-Founder and Chief Scientific Officer, Ramille Shah, and Dimension Inx Co-Founder and Chief Technical Officer, Adam Jakus, are collaborators and key personnel on an awarded Grant (#1R21DE029316-01, National Institute of Dental and Craniofacial Research, National Institutes of Health, DHHS) of which author S. Sydlik is the principal investigator and author C. Laurencin is a collaborator and key personnel. Thus, there is a current and ongoing collaboration outside of this work between the corresponding authors (C. Laurencin and S. Sydlik) and Dimension Inx. L. Daneshmandi, B. D. Holt, and A. M. Arnold have no competing interests to declare.